Pembrolizumab

Category: Cancer



Pembrolizumab Overview

Pembrolizumab, sold under the brand name Keytruda, is a humanized antibody used in cancer immunotherapy that treats melanoma, lung cancer, head and neck cancer, Hodgkin lymphoma, and stomach cancer.[5] It is given by slow injection into a vein.[5] Common side effects include fatigue, musculoskeletal pain, decreased appetite, itchy skin (pruritus), diarrhea, nausea, rash, fever (pyrexia), cough, difficulty breathing (dyspnea), constipation, pain, and abdominal p...

Read more Pembrolizumab Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Pembrolizumab

Recent Pembrolizumab Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Pembrolizumab
  • Powder, For Injection Solution, Lyophilized Powder: 50mg
  • Solution: 100mg/4ml (25mg/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Pembrolizumab or a similar ingredient: (1 result)

Related Pembrolizumab Topics:

Pembrolizumab and Glutathione
My husband is in immunotherapy, undergoing 1 infusion of pembrolizumab ('Keytruda') every three weeks. Is it hel...